And in a large sample size of breast cancer microarray analysis, the expression of TFDP3 was related with HER2-overexpression subtype of breast cancer, it indicated that TFDP3 may play an important role in the diagnosis and drug-resistant of HER2-overexpression breast cancer. This evidence concerns the gene ERBB2 and breast cancer.